WASHINGTON: Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as those whose hormone…
COPENHAGEN: Evelyn O’Flynn still has lung cancer. But after going straight on to a new immune system-boosting drug more than a year ago, rather than…
But in reality, Microsoft’s involvement in several cancer-curing projects makes complete and total sense. Apart from the already well-established, well-oiled philanthropic machine that is the…